Insmed nets $378mm via FOPO

19:41 EDT 8 Sep 2017 | Elsevier Business Intelligence

Respiratory disease-focused Insmed Inc. netted $378mm through a follow-on public offering of 14.12mm common shares (including...

Original Article: Insmed nets $378mm via FOPO


More From BioPortfolio on "Insmed nets $378mm via FOPO"

Quick Search

Relevant Topics

Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...